# Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

> **NCT00042913** · PHASE2 · UNKNOWN · sponsor: **Jonsson Comprehensive Cancer Center**

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** epratuzumab

## Key facts

- **NCT ID:** NCT00042913
- **Lead sponsor:** Jonsson Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00042913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00042913, "Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00042913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*